Research and Public Health Funding
The American Society of Hematology urges Congress to recognize the value of biomedical research by providing the NIH with sustained, meaningful growth above inflation in fiscal year (FY) 2023.
Take Action: While Congress works on assembling bills to provide funding for NIH and other important research and public health programs, lawmakers need to hear from constituents about the impact that research funding has on hematology.
Send a letter to Congress urging support for increased NIH funding.
In addition to constituent letters to lawmakers, the Society regularly sends messages to policy makers in Washington, DC.
Recent correspondence on NIH funding:
- FRIENDS OF NIDDK LETTER ON FY 2022 FUNDING
- AD HOC GROUP LETTER URGING SWIFT PASSAGE OF FY22 APPROPRIATIONS
- ORGANIZATIONAL SIGN-ON LETTER TO CONGRESSIONAL LEADERSHIP ON FY 2022
The American Society of Hematology urges Congress to Provide at least $10 million in FY 2023 for the Sickle Cell Data Collection program at the Centers for Disease Control and Prevention (CDC). This program will improve the understanding of health outcomes and health care system utilization patterns of people with SCD.
Also, increased funding for the CDC is important because of the crucial role the CDC plays in preventing and controlling clotting, bleeding, and other hematologic disorders.
Blood disorders such as sickle cell disease, anemia, blood clots, and hemophilia – are a serious public health problem and affect millions of people each year in the United States, cutting across the boundaries of age, race, sex, and socioeconomic status.
ASH works with other members of the public health community to advocate for increased funding to strengthen all of CDC’s programs.
Additional CDC Programs:
Correspondences sent on CDC funding:
For questions on Research and Public Health Funding or to find out how you can get involved in ASH's advocacy efforts, reach out to Tracy Roades, Senior Manager, Legislative Advocacy.